HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.

Abstract
The safety of low platelet thresholds for prophylactic transfusions was retrospectively evaluated in 673 children with various thrombocytopenic disorders. In patients with idiopathic thrombocytopenic purpura and X linked thrombocytopenia the threshold for the use of platelet transfusion was based on bleeding events rather than platelet count. In children with hypoproliferative thrombocytopenia and Wiskott-Aldrich syndrome, prophylactic platelet transfusions were used when the platelet count was <or= 5000/microl in stable patients and > 10,000/microl in cases of bleeding or infections. The restrictive policy of platelet transfusions was shown to be proved safe in many thrombocytopenic disorders.
AuthorsM Ferrara, L Capozzi, A Coppola, G Save, L Coppola
JournalHematology (Amsterdam, Netherlands) (Hematology) Vol. 12 Issue 4 Pg. 297-9 (Aug 2007) ISSN: 1607-8454 [Electronic] England
PMID17654055 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adolescent
  • Adult
  • Anemia, Aplastic (complications, therapy)
  • Child
  • Child, Preschool
  • Fanconi Anemia (complications, therapy)
  • Female
  • Follow-Up Studies
  • Genetic Diseases, X-Linked (complications, therapy)
  • Hemorrhage (etiology)
  • Humans
  • Male
  • Platelet Count (statistics & numerical data)
  • Platelet Transfusion (adverse effects, statistics & numerical data)
  • Purpura, Thrombocytopenic, Idiopathic (therapy)
  • Retrospective Studies
  • Severity of Illness Index
  • Thrombocytopenia (etiology, genetics, therapy)
  • Wiskott-Aldrich Syndrome (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: